FDA chief pleads agency's case for more cash
This article was originally published in Scrip
In yet another appearance before a congressional committee to plead for more dollars, US FDA Commissioner Dr Margaret Hamburg reminded lawmakers that her agency, which is only seeking a "modest" increase in its allowance for fiscal year 2013, receives "thousands of medical product submissions each year," and serves as the "watchdog for tens of thousands of products" already on the US market.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.